The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
Open accessAbstract
BACKGROUND: The two main constituents of cannabis, cannabidiol and Δ(9)-tetrahydrocannabinol (THC), have opposing effects both pharmacologically and behaviourally when administered in the laboratory. Street cannabis is known to contain varying levels of each cannabinoid. AIMS: To study how the varying levels of cannabidiol and THC have an impact on the acute effects of the drug in naturalistic settings. METHOD: Cannabis users (n = 134) were tested 7 days apart on measures of memory and psychotomimetic symptoms, once while they were drug free and once while acutely intoxicated by their own chosen smoked cannabis. Using an unprecedented methodology, a sample of cannabis (as well as saliva) was collected from each user and analysed for levels of cannabinoids. On the basis of highest and lowest cannabidiol content of cannabis, two groups of individuals were directly compared. RESULTS: Groups did not differ in the THC content of the cannabis they smoked. Unlike the marked impairment in prose recall of individuals who smoked cannabis low in cannabidiol, participants smoking cannabis high in cannabidiol showed no memory impairment. Cannabidiol content did not affect psychotomimetic symptoms, which were elevated in both groups when intoxicated. CONCLUSIONS: The antagonistic effects of cannabidiol at the CB(1) receptor are probably responsible for its profile in smoked cannabis, attenuating the memory-impairing effects of THC. In terms of harm reduction, users should be made aware of the higher risk of memory impairment associated with smoking low-cannabidiol strains of cannabis like 'skunk' and encouraged to use strains containing higher levels of cannabidiol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adolescents at risk of substance use problems may display cognitive vulnerabilities, 17,[117][118][119][120] which could partially contribute to cognitive findings described here, although they do not exclude the possibility of additional deficits.”
From Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis (2018) · cites this paper as [118]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Two recent, largescale studies also question the specificity of cannabis as a causal factor in predicting cognitive change after adjusting for confounding variables and familial factors.118,121”
From Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis (2018) · cites this paper as [118]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria
Raine, A. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.555 · Cited by 2,164
Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Gossop, M., Darke, S. G., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995) · Addiction · doi:10.1046/j.1360-0443.1995.9056072.x · Cited by 1,341
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Rivermead Behavioural Memory Test
la Cour, P., & GALLAGHER, K. (1990) · Nordisk Psykologi · doi:10.1080/00291463.1990.10636996 · Cited by 992
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Wechsler Test of Adult Reading
(2001) · PsycTESTS Dataset · doi:10.1037/t15180-000 · Cited by 616
An event-related potential study of recognition memory with and without retrieval of source
Wilding, E. L., & Rugg, M. D. (1996) · Brain · doi:10.1093/brain/119.3.889 · Cited by 578
High-potency cannabis and the risk of psychosis
Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.064220 · Cited by 567
Self-citationThe acute effects of cannabinoids on memory in humans: a review
Ranganathan, M., & D’Souza, D. C. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0508-y · Cited by 544
Gossop, M., Darke, S. G., Griffiths, P., et al. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb02199.x · Cited by 500
Brief Psychiatric Rating Scale
Overall, J. E., & Gorham, D. R. (1962) · PsycTESTS Dataset · doi:10.1037/t01554-000 · Cited by 498
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400001 · Cited by 415
Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug
Solowij, N., Hall, W., & Lee, N. (1992) · British Journal of Addiction · doi:10.1111/j.1360-0443.1992.tb02003.x · Cited by 408
Antianxiety effect of cannabidiol in the elevated plus-maze
Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379
Curran, V. H., Brignell, C. M., Fletcher, S., Middleton, P. M., & Henry, J. A. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1169-0 · Cited by 370
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300
Self-citationD’Souza, D. C., Ranganathan, M., Braley, G., Gueorguieva, R. V., Zimolo, Z., Cooper, T. B., Perry, E. B., & Krystal, J. H. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301643 · Cited by 271
Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans
Krystal, J. H., Karper, L. P., Bennett, A., D’Souza, D. C., Abi‐Dargham, A., Morrissey, K., Abi‐Saab, D., Bremner, J. D., Bowers, M. B., Suckow, R. F., et al. (1998) · Psychopharmacology · doi:10.1007/s002130050503 · Cited by 184
Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids
Ilan, A. B., Gevins, A., Coleman, M., Elsohly, M., & de Wit, H. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00023 · Cited by 169
Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance
González, R. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9036-8 · Cited by 140
Hippocampal CB1 Receptors Mediate the Memory Impairing Effects of Δ9-Tetrahydrocannabinol
Wise, L. E., Thorpe, A. J., & Lichtman, A. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.31 · Cited by 136
Mason, O. J., Morgan, C. J. M., Stefanovic, A., & Curran, H. V. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.02.020 · Cited by 135
Hermann, D., Sartorius, A., Welzel, H., Walter, S., Skopp, G., Ende, G., & Mann, K. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.027 · Cited by 135
DEOLIVEIRAALVARES, L., De-Oliveira, L. M., de Almeida, C. C. S., Diehl, F., Genro, B. P., Lanziotti, V. M. N. B., & Quillfeldt, J. A. (2004) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2004.10.002 · Cited by 108
Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis
Mason, O. J., Morgan, C. J. A., Dhiman, S. K., Patel, A., Parti, N., Patel, A., & Curran, H. V. (2008) · Psychological Medicine · doi:10.1017/s0033291708004741 · Cited by 71
Effects of a third party observer and anxiety on tests of executive function☆☆☆
Horwitz, J. E., & MCCAFFREY, R. (2008) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2008.02.002 · Cited by 48
An event-related potential study of recognition memory with and without retrieval of source
Wilding, E. L., & Rugg, M. D. (1996) · Brain · doi:10.1093/brain/119.4.1415-a · Cited by 34
Cappell, H., Kuchar, E., & Webster, C. D. (1973) · Psychopharmacology · doi:10.1007/bf00414031 · Cited by 31
The effects of depression on structural aspects of the recall of prose.
Watts, F., & Cooper, Z. (1989) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.98.2.150 · Cited by 20
The effects of depression on structural aspects of the recall of prose.
Watts, F., & Cooper, Z. (1989) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.98.2.150 · Cited by 15
Research works printed but not linked: 5
- 10.1038/sj.npp.1300496 · DOI · Paper page
- 2006, Annual Report 2006: The State of the Drugs Problem in Europe
- 2009, Health Survey Findings for England 2008
- Hardwick, 2008, Home Office Cannabis Potency Study
- 10.1016/j.biopsych.2006.08.027 · DOI
Cited by
Sorted by citations
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
Devinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
Cannabidiol as a Potential Treatment for Anxiety Disorders
Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 752
Metadata
- Authors
- Morgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V.
- Affiliations
- University College London (GB)
- Corresponding author
- Curran, H. Valerie
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2010-10
- Volume
- 197
- Issue
- 4
- Pages
- 285-290
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2015441565
- Cited by
- 305
- References
- 30
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 8 · 2023: 23 · 2022: 13 · 2021: 20 · 2020: 31 · 2019: 24 · 2018: 26 · 2017: 25 · 2016: 22 · 2015: 20 · 2014: 20 · 2013: 17 · 2012: 23
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The British Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Keywords
- cannabidiol, delta-9-tetrahydrocannabinol, cannabis smoking, psychotomimetic effects, CB1 receptor antagonism, harm reduction, prose recall, cannabis users
- MeSH terms
- Adolescent, Alcohol Drinking, Analysis of Variance, Cannabidiol, Cannabinoids, Female, United Kingdom, Humans, Male, Marijuana Smoking, Memory, Memory Disorders, Psychiatric Status Rating Scales, Mental Recall, Saliva, Dronabinol, Verbal Learning, Receptor, Cannabinoid, CB1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
